Ventricular tachycardia is a life threatening heart condition in which arrhythmic heart beats occur in the ventricles. The two lower chambers of the heart are known as ventricles. They are responsible for supplying the blood received from atria to different parts of the body. When a person suffers from ventricular tachycardia, a high pulse with more than 100 beats per minute is registered with minimum 3 irregular heartbeats experienced in a row. It is most commonly indicated in patients having acute myocardial infarction, electrolyte abnormalities and idiopathic ventricular arrhythmia in heart. Ventricular tachycardia should be correctly diagnosed in time as it may lead to hemodynamic instability causing ventricular fibrillation, thereby becoming a major reason behind deaths due to cardiac attacks. Ventricular tachycardia can be further classified into four different types which includes monomorphic, polymorphic, sustained and non-sustained ventricular tachycardia. In non-sustained ventricular tachycardia, heartbeat stops impulsively without disturbing the blood flow; whereas, in sustained ventricular tachycardia arrhythmic heartbeats persists for more than 30 seconds and they usually disrupts the blood flow by lowering it. However, in monomorphic ventricular tachycardia, the heartbeats follow a same rhythmic wave pattern and rhythmic pattern varies in case of polymorphic ventricular tachycardia. People who previously had a heart attack or suffers from heart conditions such as myocardial infarction, structural heart disease, ischemic heart disease and are older in age are more likely at the risk of experiencing ventricular tachycardia. Some of the main symptoms for ventricular tachycardia includes fatigue, chest pain, fainting, shortened breath, dizziness, palpitations, cardiac arrests and seizures. It needs to be properly diagnosed in time by performing following diagnostic tests such as electrocardiogram; cardiac imaging which includes echo, MRI, CT scan, coronary angiogram and chest X-ray; stress test; electrophysiological test and other tests.
Depending upon the symptoms and severity of heart disorder, ventricular tachycardia treatment is broadly classified into two categories: emergency treatment for patients in distress and long-term treatment. Various anti-arrhythmic drugs such as Aminodarone, Lidocaine, Sotalol, Procainamide and Nifekalant are most commonly preferred to treat patients with ventricular tachycardia. These drugs treat unusual heart rhythms that originates due to error in electrical activity of heart.
Get Sample Copy of this report at https://www.persistencemarketresearch.com/samples/17389?source=atm
Rising incidence of heart injuries such as myocardial infarctions and valvular heart disease is anticipated to be the primary factor fueling the ventricular tachycardia treatment market. Growing geriatric population with rising heart conditions such as heart attacks, changing lifestyle, rising inclination of patients for cardiomyopathy and heart surgery are some other factors which further drive the ventricular tachycardia treatment market. Moreover, advancing technology and enhanced treatment therapies is further anticipated to drive the market over forecast period. However, high costs associated with heart surgeries is restraining the current market growth.
The global market for ventricular tachycardia treatment is segmented on basis of disease indication, treatment type and geographic region: Segmentation by Disease Indication Monomorphic Ventricular Tachycardia Polymorphic Ventricular Tachycardia Sustained Ventricular Tachycardia Non-Sustained Ventricular Tachycardia Segmentation by Treatment Type Emergency Treatment CPR Electrical Defibrillation Direct-Current Cardioversion Therapy Anti-arrhythmic Drugs Local Injectable Anesthetics Cardioselective Beta Blockers Class I Antiarrhythmic Drugs Class II Antiarrhythmic Drugs Class III Antiarrhythmic Drugs Long-Term Treatment Implanted Cardiovascular Defibrillation (ICD) Radiofrequency Catheter Ablation Cardiac Resynchronization Therapy Open Heart Surgery Segmentation by Geography North America Latin America Europe Asia-Pacific Middle East & Africa
On the basis of type of treatment, catheter ablation is most common treatment technique used to restore common rhythmic heartbeats. Also, owing to the promising success rates associated with catheter ablation treatment procedure, it is further anticipated to dominate over the forecast period.
Request to View TOC at https://www.persistencemarketresearch.com/toc/17389?source=atm
Based on geography, global ventricular tachycardia treatment market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America registered for the largest shares in global ventricular tachycardia treatment market followed by Europe and Asia-Pacific. North America region is anticipated to continue the same trend on the account of rise in number of deaths due to cardiac fatalities in U.S.
Some of the key players involved in global ventricular tachycardia treatment market are INOVYTEC MEDICAL SOLUTIONS Ltd., CU Medical Systems, Inc., Cardiac Science Co., Bexen Cardio, Advanced Instrumentations Inc., Baxter International Inc., Pfizer Inc., Heritage Pharmaceuticals Inc. and others.
The report covers exhaustive analysis on: Ventricular Tachycardia Treatment Market Segments Ventricular Tachycardia Treatment Market Dynamics Historical Actual Market Size, 2012 2016 Ventricular Tachycardia Treatment Market Size & Forecast 2016 to 2024 Ventricular Tachycardia Treatment Market Current Trends/Issues/Challenges Competition & Companies involved Ventricular Tachycardia Treatment Market Drivers and Restraints
Regional analysis includes North America Latin America Europe Asia Pacific Middle East & Africa
Report Highlights: Shifting Industry dynamics In-depth market segmentation Historical, current and projected industry size Recent industry trends Key Competition landscape Strategies of key players and product offerings Potential and niche segments/regions exhibiting promising growth A neutral perspective towards market performance
Get Full Access of this report at https://www.persistencemarketresearch.com/checkout/17389?source=atm
Read the original:
- ST-Segment Elevation Myocardial Infarction - verywell.com - May 12th, 2018 [May 12th, 2018]
- Myocardial infarction (Heart Attack) - Health Facts - June 21st, 2018 [June 21st, 2018]
- Heart Attack and Acute Coronary Syndrome - Lab Tests Online - June 21st, 2018 [June 21st, 2018]
- Myocardial Infarction - ECGpedia - September 21st, 2018 [September 21st, 2018]
- Myocardial Infarction Clinical Presentation: History ... - September 25th, 2018 [September 25th, 2018]
- Myocardial infarction diagnosis - Wikipedia - September 25th, 2018 [September 25th, 2018]
- Myocardial Infarction Treatment & Management: Approach ... - October 9th, 2018 [October 9th, 2018]
- Myocardial infarction - Simple English Wikipedia, the free ... - October 18th, 2018 [October 18th, 2018]
- ST-Segment Elevation Myocardial Infarction - October 18th, 2018 [October 18th, 2018]
- ECG localization of myocardial infarction / ischemia and ... - October 18th, 2018 [October 18th, 2018]
- Heart Attack (Myocardial Infarction) Symptoms | Cleveland Clinic - November 15th, 2018 [November 15th, 2018]
- Myocardial Infarction (Heart Attack) Ischemia Pathophysiology, ECG, Nursing, Signs, Symptoms Part 1 - November 15th, 2018 [November 15th, 2018]
- Myocardial Infarction (MI) NCLEX Questions - November 30th, 2018 [November 30th, 2018]
- Myocardial Infarction NCLEX Review (Part 1) - December 3rd, 2018 [December 3rd, 2018]
- Acute Myocardial Infarction, Myocardial infection. Patient - December 4th, 2018 [December 4th, 2018]
- Heart Attack | Myocardial Infarction | MedlinePlus - December 16th, 2018 [December 16th, 2018]
- Heart Attack (Myocardial Infarction) - medicinenet.com - December 17th, 2018 [December 17th, 2018]
- Myocardial infarction (acute): Early rule out using high ... - December 20th, 2018 [December 20th, 2018]
- Conditions We Treat: Myocardial Infarction | Johns Hopkins ... - December 23rd, 2018 [December 23rd, 2018]
- Myocardial Infarction - Heart Home Page - December 25th, 2018 [December 25th, 2018]
- Myocardial infarction: signs symptoms and treatment ... - December 25th, 2018 [December 25th, 2018]
- ECGs in Acute Myocardial Infarction - ACLS Medical Training - December 25th, 2018 [December 25th, 2018]
- Myocardial Infarction - Eccles Health Sciences Library - December 27th, 2018 [December 27th, 2018]
- Myocardial Infarction: Practice Essentials, Background ... - December 27th, 2018 [December 27th, 2018]
- Myocardial infarction - Wikipedia - December 27th, 2018 [December 27th, 2018]
- Nursing Care Plan for Myocardial Infarction | NRSNG - December 29th, 2018 [December 29th, 2018]
- Cardiovascular disease - Myocardial infarction | Britannica.com - January 11th, 2019 [January 11th, 2019]
- Heart Attack (Myocardial Infarction) - Cedars-Sinai - January 11th, 2019 [January 11th, 2019]
- Top 5 MI ECG Patterns You Must Know | LearntheHeart.com - January 11th, 2019 [January 11th, 2019]
- Anterior Myocardial Infarction LITFL ECG Library Diagnosis - January 11th, 2019 [January 11th, 2019]
- Electrocardiography in myocardial infarction - Wikipedia - January 11th, 2019 [January 11th, 2019]
- Myocardial Infarction Therapeutics Market, Share, Growth ... - March 13th, 2019 [March 13th, 2019]
- Heart Attack (Myocardial Infarction) - Drugs.com - April 20th, 2019 [April 20th, 2019]
- STEMI (ST Elevation Myocardial Infarction): diagnosis ... - April 20th, 2019 [April 20th, 2019]
- Heart attack - Symptoms and causes - Mayo Clinic - April 20th, 2019 [April 20th, 2019]
- Cardiovascular models including myocardial infarction ... - April 27th, 2019 [April 27th, 2019]
- Myocardial infarction - Osmosis Video Library - May 1st, 2019 [May 1st, 2019]
- Myocardial Infarction - September 17th, 2019 [September 17th, 2019]
- Creatinine Rises After RAS Inhibitor Initiation Tied to Worse Outcomes - Renal and Urology News - September 19th, 2019 [September 19th, 2019]
- FDA Action Alert: Merck and Amarin - BioSpace - September 19th, 2019 [September 19th, 2019]
- Resverlogix Provides Update on BETonMACE Phase 3 Trial Toronto Stock Exchange:RVX - GlobeNewswire - September 19th, 2019 [September 19th, 2019]
- Marijuana Use Linked to Improved Acute-HF Hospital Survival - Medscape - September 19th, 2019 [September 19th, 2019]
- Population Health vs. Personalized Medicine: Lost in Translation? - American Council on Science and Health - September 19th, 2019 [September 19th, 2019]
- Bariatric Surgery Tied to Less MACE in Obesity, Diabetes - Medscape - September 19th, 2019 [September 19th, 2019]
- A Novel Algorithm for Improving the Diagnostic Accuracy of Prehospital ST-Elevation Myocardial Infarction - DocWire News - September 19th, 2019 [September 19th, 2019]
- Shock and Awe: ARNI for Acute HF May Be Safely Started in ICU - Medscape - September 19th, 2019 [September 19th, 2019]
- Global Myocardial Infarction Treatment Market Will Reach USD 1726.3 million by end of 2022 - Market News Store - September 19th, 2019 [September 19th, 2019]
- Frequency and Factors Related to Not Receiving Acute Reperfusion Therapy in Patients with ST Elevation Myocardial Infarction; A Single Specialty... - September 19th, 2019 [September 19th, 2019]
- Research Offers 10-Year Forecast on Myocardial Infarction Treatment Market - Rapid News Network - September 19th, 2019 [September 19th, 2019]
- University of Colorado study suggests Cannabis aids in surviving heart... - Communities Digital News - September 19th, 2019 [September 19th, 2019]
- SRH part of regional system award recognizing care for heart attacks - Index-Journal - September 19th, 2019 [September 19th, 2019]
- TherOx Announces Key SuperSaturated Oxygen Therapy Presentations at TCT 2019 - Yahoo Finance - September 19th, 2019 [September 19th, 2019]
- Incidence, Characteristics and Outcomes in Very Young Patients with ST Segment Elevation Myocardial Infarction - DocWire News - September 19th, 2019 [September 19th, 2019]
- Health Recovery After Acute MI Similar in Young Adults With and Without Diabetes - The Cardiology Advisor - September 19th, 2019 [September 19th, 2019]
- Rapid Diagnosis Protocol for Chest Pain Does Not Improve Outcomes - Diagnostic and Interventional Cardiology - September 19th, 2019 [September 19th, 2019]
- Diagnosis of Myocardial Infarction At Autopsy: AECVP Reappraisal in the Light of the Current Clinical Classification - DocWire News - September 19th, 2019 [September 19th, 2019]
- Global Myocardial Infarction Drug Market 2019 BioCardia, Inc., Biscayne Pharmaceuticals, Inc., Capricor Therapeutics, Inc., Cell - Market News Times - September 19th, 2019 [September 19th, 2019]
- Abiomed to Highlight Importance of Optimal PCI Treatment to Improve Outcomes for High-Risk Patients at TCT 2019 - Yahoo Finance - September 19th, 2019 [September 19th, 2019]
- ENTRUST-AF PCI Supports Safety of Dual Therapy With Edoxaban - Medscape - September 19th, 2019 [September 19th, 2019]
- Preoperative opioid use leads to perioperative consequences in foot and ankle surgery - Healio - September 19th, 2019 [September 19th, 2019]
- CV, General Safety of Long-Term PPI Use Examined - The Cardiology Advisor - September 19th, 2019 [September 19th, 2019]
- Effect of Delayed vs Immediate Interventions in Transient STEMI - The Cardiology Advisor - September 19th, 2019 [September 19th, 2019]
- Cardiorenal Disease Is the Most Common CVD Manifestation in Patients With T2D - Endocrinology Advisor - September 19th, 2019 [September 19th, 2019]
- DAPA-HF Published: 'Stunning Consistent Benefit With Dapagliflozin' - Medscape - September 19th, 2019 [September 19th, 2019]
- Geomagnetic Disturbances and Cardiovascular Mortality Risk - On Health - BMC Blogs Network - September 19th, 2019 [September 19th, 2019]
- Reconsidering the Safety of Intravenous Thrombolysis for Ischemic Stroke After Recent Myocardial Infarction - Neurology Advisor - September 19th, 2019 [September 19th, 2019]
- The Lowdown on Lipoprotein(a) - Medscape - October 9th, 2019 [October 9th, 2019]
- Protamine use found to significantly reduce reoperations for patients who undergo carotid endarterectomy - Vascular News - October 9th, 2019 [October 9th, 2019]
- Left Main Treated With PCI or CABG Have Similar Outcomes at Five Years - Diagnostic and Interventional Cardiology - October 9th, 2019 [October 9th, 2019]
- Sen. Sanders released from the hospital after heart attack - WXYZ - October 9th, 2019 [October 9th, 2019]
- E-Selectin Gene Haplotypes are Associated with the Risk of Myocardial Infarction - DocWire News - October 9th, 2019 [October 9th, 2019]
- BioVentrix Enrolls and Treats First Patient in REVIVE-HF European RCT for Ischemic Heart Failure Patients - P&T Community - October 9th, 2019 [October 9th, 2019]
- Quantitative Flow Ratio guided Residual Functional SYNTAX Score for Risk Assessment in Patients with ST-Segment Elevation Myocardial Infarction... - October 9th, 2019 [October 9th, 2019]
- Coronary Calcium Scan: The Role of Calcium Scoring in Preventing a First Myocardial Infarction - Consultant360 - October 9th, 2019 [October 9th, 2019]
- Sanders plans to 'change the nature' of campaign after heart attack - New York Post - October 9th, 2019 [October 9th, 2019]
- Early MI Linked to High Recurrent Events, Mortality - Medscape - October 9th, 2019 [October 9th, 2019]
- Sudden Cardiac Arrest and Ventricular Arrhythmias following first type I Myocardial Infarction in the Contemporary Era - DocWire News - October 9th, 2019 [October 9th, 2019]
- E-Cigarette Use and Myocardial Infarction - Physician's Weekly - October 9th, 2019 [October 9th, 2019]
- Sen. Bernie Sanders had heart attack; chest pains diagnosed as myocardial infarction - KIRO Seattle - October 9th, 2019 [October 9th, 2019]
- High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction - DocWire News - October 9th, 2019 [October 9th, 2019]